Background Earlier studies have documented that the prevalence of decreased bone mineral density (BMD) is elevated in patients with inflammatory bowel disease. The objective of this study was to investigate the prevalence of vertebral deformities in inflammatory bowel disease patients and their relation with BMD and bone turnover.
Introduction
Decreased bone mineral density (BMD) is a frequent finding in inflammatory bowel disease (IBD). Z-scores of less than -1.0 can be found in 32-38% of patients with Crohn's disease (CD) and in about 25% of patients with ulcerative colitis (UC) [1] . An even higher prevalence of decreased bone mass can be found when a T-score is used to express BMD. Following this approach, in an earlier study we found osteopenia and osteoporosis in, respectively, 45 and 13% of patients with CD [2] .
Specific disease-related factors contributing to decreased BMD in IBD patients involve inflammatory cytokines with associated increased bone resorption, malabsorption because of disease activity or extensive intestinal resection, glucocorticoid (GC) use, inability to achieve peak bone mass when the disease starts in childhood, malnutrition and hypogonadism induced by the chronic inflammatory condition, and eventually superposed on other clinical risk factors such as history of fracture, family history of fractures, immobilization, low body mass index (BMI), smoking, and alcohol abuse [1] [2] [3] [4] [5] [6] [7] . hip, rib, and forearm fractures compared with controls, 1.7 (95% CI: 1.3-2.2) for clinical vertebral fractures and 1.6 (95% CI: 1.3-2.0) for hip fractures, with similar increases for CD and UC [8] . In a primary care-based case-control study, similar increases in the risk of clinical vertebral and hip fractures were found in patients with IBD [9] . In a large Danish case-control study, a 2.5-fold increase in the risk of symptomatic low-energy fractures of spine, feet, and toes was found among women with CD, but not in men or patients with UC [10] . In a recent extensive review, Bernstein and Leslie [11] concluded that patients with IBD have a moderately increased risk of clinical fractures but mentioned a lack of studies on the presence of morphometric vertebral fractures and the absence of data in UC.
Indeed, the majority of studies on fractures in IBD concern clinical fractures. Vertebral fractures, in particular, are often not clinically recognized and can accumulate silently [12] . It is well established that a vertebral fracture, clinical or morphometric only, is a strong risk factor for subsequent osteoporotic fractures, not only at the spine but also at other sites and regardless of BMD [13] [14] [15] [16] . Furthermore, vertebral fracture risk is related to the number and severity of prevalent vertebral fractures, whereas the risk of nonvertebral fractures is related to the severity of prevalent morphometric vertebral fractures [16, 17] .
Data on the prevalence of morphometric vertebral fractures in patients with IBD are scarce. A prevalence of 22% was found on radiograph findings using a decrease in anterior, mid, or posterior height of more than 20% in a study of 156 patients with CD and osteopenia or osteoporosis, ranging from 20% in patients less than 20 years old to 50% in patients older than 60 years [18] . In another study, a prevalence of morphometric vertebral fractures on radiograph findings (any height loss of > 20%) of 14% was found (11% in patients < 30 years up to 31% in patients older than 60 years), with no correlation with BMD and use of GCs [19] . The prevalence of morphometric vertebral fractures in UC is not known.
For these reasons, we investigated in a cohort of 181 patients with IBD, including CD as well as UC patients, the prevalence of morphometric vertebral deformities. The findings were related to BMD, bone turnover parameters and clinical risk factors, to get an impression about the risk of vertebral fractures in IBD patients and the extent to which this is related to differences in BMD and bone turnover.
Patients and methods

Patients
Between January 2002 and July 2003, all patients with IBD who had a disease duration of at least 1 year, and attended the outpatient clinic of the University Hospital Maastricht, were asked to participate in this crosssectional study. Two hundred and two patients (78%) agreed. All patients were Caucasians and diagnosed with CD or UC on clinical grounds using endoscopic and/or radiological evidence, and by histological investigation of mucosal biopsies and/or surgical specimens when available. For confirmation of the CD diagnosis the Lennard-Jones criteria [20] and for UC the Truelove and Witts criteria [21] were applied. Sixteen patients with known causes of bone mass abnormalities, such as renal failure, thyroid dysfunction, alcoholism, and ankylosing spondylitis, were excluded. None of the other patients had any significant comorbidity. Five patients were excluded because of incomplete data. Thus, 181 patients were included in this study. This group consisted of 81 premenopausal women, 26 postmenopausal women, and 74 men. Demographic, clinical, and treatment data of these patients are summarized in Table 1 . The clinical records of all patients were reviewed. Age of onset of CD and UC, disease duration, and medication use were derived from the medical records. GC use was scored as never, earlier (stopped more than 3 months before including in the study), or current. If patients were currently using GCs the daily dose was noted. Furthermore, current use of other immunosuppressive medication, vitamin D and calcium, or budenoside use were also recorded.
Patients were evaluated according to a standard protocol that included measurement of height and weight, measurement of BMD, and collection of a blood sample and morning urine.
Calcium intake of all patients was scored on the basis of a detailed dietary list. Known clinical risk factors for osteoporosis (weight below 60 kg, hip fracture in the mother, history of fractures after age of 50 years, menopausal status, and severe immobilization) as well as daily activities and exercise were assessed by a validated questionnaire [22] , in which sports, daily and work activities were scored with a minimum of zero and a maximum of 18. Current disease activity in CD was evaluated using the Crohn's disease activity index (CDAI) [23] and in UC the colitis activity index (CAI) [24] was applied. Patients with CD were considered to have active disease when CDAI was more than 150. Informed consent was obtained from all participants and this study was approved by the ethical committee of the hospital.
Laboratory assays
As a marker for bone formation, serum procollagen type I amino-terminal propeptide (PINP) was measured. As a marker for bone resorption, serum carboxy-terminal crosslinked telopeptide of type I collagen (ICTP) was assessed. Both PINP [interassay coefficient of variation (IE-CV) 3.2%, intra-assay coefficient of variation (IA-CV) 2.5%, lowest detectable concentration 0.4 mg/l] and ICTP (IE-CV 3.5%, IA-CV 2.3%, lowest detectable concentration < 0.1 mg/l) were measured using commercial radioimmunoassay (RIA) kits (Orion Diagnostica Oy, Espoo, Finland). The Z-score for these bone markers was obtained using a Dutch reference group (300 women, 150 men), checked for normal BMD of the lumbar spine and femur and normal 25-hydroxyvitamin D levels. Serum 1,25-dihydroxyvitamin D concentration was determined by RIA using a commercially available kit (IDS Ltd, Boldon, England; IE-CV 11%, IA-CV 15%).
Bone mineral density and morphometry
In all 181 patients, BMD of the hip was measured by dual X-ray absorptiometry (DXA; Hologic QDR 4500; Tromp Medical, Castricum, The Netherlands). As a reference group, the NHANES III database was used. Measurements were done in the standard projection, and results were reported for femoral neck (FN) and trochanter. Standard procedures supplied by the manufacturer for scanning and analyses were performed. Calibration with the manufacturer's spine phantom and quality control analysis was performed daily. The coefficient of variation for BMD measurements was 1.0%. The number of patients with osteopenia and osteoporosis was determined according to the WHO classification in which osteopenia was defined as a T-score between -1 and -2.5 and osteoporosis as a T-score less than or equal to -2.5. To adjust for age and sex, Z-scores were used. Furthermore, after bone density measurement a lateral, single-energy densitometry of the thoracic and lumbar spine was performed for vertebral fracture assessment [also called morphometric X-ray absorptiometry (MXA)] [25] . The scans obtained were analyzed twice by one trained operator (intraobserver correlation: 0.85), using the quantitative method of Genant et al. [26] and also a visual assessment was done. Six points were placed on each vertebral body. From these points three vertebral heights were measured: anterior, mid, and posterior. On the basis of the average score of these morphometric measurements, ratios were calculated and a prevalent vertebral deformity was defined as a reduction of height of 20% or more [26] . For crush, deformity ratio was calculated by dividing posterior height of the vertebra with posterior height of the vertebra below. Grade 1 (mild) deformity was defined as a reduction of 20-25% in any height, grade 2 (moderate) 25-40%, and grade 3 more than 40% reduction (severe).
Statistics
Student's t-tests, w 2 tests, and one-way analyses of variance were used, depending on the variables and subgroups tested. The analyses were performed with Z-scores to correct for age and sex when comparing (sub)groups. One-sample t-tests were used to compare patient scores with norm scores. A logistic regression analysis was performed to examine the determinants of morphometric vertebral deformities. Sex, age, weight, disease, illness duration, CDAI, CAI, physical activity, vitamin D, GC use, current use of vitamin D, calcium, immunosuppressive medication, budenoside, and hip fracture of mother were examined as potential determinants. Furthermore, we analyzed the risk factors for having more than one vertebral deformity.
Results
Bone mineral density
The results of BMD measurements and bone turnover markers are shown in Table 2 . In the total group, osteoporosis was found in 4% of patients and osteopenia in 55%. Excluding patients currently using GCs and/or bisphosphonates, the average Z-score of the FN was decreased compared with the reference population ( -0.29, 95% CI: -0. 
Bone turnover parameters
In the total group of patients currently not on bisphosphonates and/or GCs the average Z-score for ICTP (Z-ICTP) was increased compared with the reference population (0.49, 95% CI: 0.22, 0.76; P < 0.001), as well as the marker of bone formation (Z-PINP) (0.59, 95% CI: 0.31, 0.86; P < 0.001). This was especially observed in patients with CD (Z-ICTP: 0.53, 95% CI: 0.19, 0.88; P < 0.01 and Z-PINP: 0.69, 95% CI: 0.36, 1.03; P < 0.001, respectively).
Morphometric vertebral deformities
Vertebral deformities (ratio of < 0.80) were found in 77 vertebrae of 45 patients (25% of total group). This prevalence was similar in both subgroups of patients. Fifty-nine of the deformities were wedge deformities, 16 biconcave, and two crush deformities. Fifty-one were mildly deformed, 22 moderate, and four severe deformations were seen. With regard to the localization of the deformities (Table 3) , prevalence peaks were found in the low thoracic region. Seventeen patients (age 51.5 ± 17.0 years) had more than one vertebral deformity. This group consisted of 11 men, three premenopausal, and three postmenopausal women. The majority of these patients (82%) were current or earlier GC users.
Comparing the groups with and without vertebral deformities, no significant difference was found between Z-scores or T-scores of BMD of the trochanter or FN, nor in Z-ICTP, or Z-PINP (Table 4 , Fig. 1 ). The two differences between these groups were an older age (P < 0.05) and more males (P < 0.01) in the group with deformities. Furthermore, no differences were seen between the two subgroups in current use of calcium and/or vitamin D supplements, aminosalicylates, immunosuppressive medication, and budenoside. Logistic regression analysis revealed that the only determinant of prevalent morphometric vertebral deformity was sex [odds ratio (OR): 2.25, P < 0.05, 95% CI: 1.11, 4.54], indicating that men have a more than two-fold higher chance of morphometric vertebral deformity. In addition, the only determinants for having more than one vertebral deformity were age (OR: 1.05, P = 0.02, 95% CI: 1.05-1.09) and current GC use (OR: 4.98, P = 0.01, 95% CI: 1.42, 17.49).
Discussion
In our series of patients with IBD, we found vertebral deformities with quantitative MXA in 25% of patients. This high prevalence is remarkable as the majority of our patients were relatively young and premenopausal. Our observations of an increased prevalence of morphometric vertebral deformities are in line with the few clinical studies reported on vertebral deformities in CD. Stockbrügger and coworkers [19] found on radiograph findings a prevalence of 14% in a younger population with CD and this increased to 43% in female patients above 60 years. In another study on 156 patients with CD and osteopenia and osteoporosis, a prevalence of 22% of vertebral deformities was found [18] . Other studies also revealed an increased risk for clinical vertebral fractures in both CD and UC [8, 9, 27] . Our finding of a preferential localization of vertebral fractures at the mid and lower thoracic spine is also in line with earlier findings [19] . In addition, an increase of morphometric vertebral fractures similar to CD was found in UC, which has not been reported in the literature before.
To what extent the high prevalence of vertebral deformities in IBD differs from participants without IBD is uncertain, as no data on nonclinical deformities in healthy young and premenopausal individuals are available. The best comparison with healthy patients for this study stems from the European vertebral osteoporosis study, in which in a very large cross-sectional populationbased study of European participants aged 50-79 years was investigated. The prevalence of vertebral deformities on radiograph findings in this study was 12% (range: 6-21%) in males and females [28] . The Rotterdam study, in which 3469 men and women aged 55 years and older were studied, revealed a prevalence of vertebral deformity suggestive of fracture in 6.9% of men and 7.5% of women [29] . In an earlier study on 60 patients (mean age 49 ± 13 years), who were followed after an initial successful treatment for differentiated thyroid carcinoma, we found vertebral deformities in 7% [30] . All these data support the fact that IBD is a relevant risk factor for vertebral deformity suggestive for fracture.
For the determination of vertebral fractures, a variety of morphometric approaches can be used. These different approaches can result in slightly different outcomes [26, [31] [32] [33] . Compared with subjective qualitative assessment, quantitative morphometry is a more reproducible method for assessing vertebral deformity and therefore these approaches are often used in conjunction. As, T6  5  3  2  -T7  1  1  --T8  4  2  2  -T9  6  5  1  -T10  7  5  2  -T11  23  15  7  1  T12  19  12  5  2  L1  5  4  1  -L 2  3  1  1  1  L3  2  1  1  -L4  2 however, a gold standard for vertebral fracture is not available, it is still not clear which method is the most appropriate to establish vertebral deformities and, on the basis of that, to determine the occurrence of vertebral fractures. We followed the method of Genant et al. [26] , which is based on a reduction of the ratios of anterior, middle, or posterior heights. This is the simplest and most practical method [31] . It is also the method used in the majority of studies on IBD patients published [18] and an association with future fracture risk is documented [16] . The above-mentioned European vertebral osteoporosis study, however, applied the methodology described by McCloskey et al. [32] and Eastell and coworkers [33] in which measurements are corrected for normal variations in vertebral shape. Relative to the method of Genant et al., the method of Eastell et al. may result in lower prevalence of vertebral deformities. In our series, use of the method of Eastell et al. resulted in vertebral deformities in 20% of patients (data not shown), which is indeed lower than the prevalence found after the method of Genant et al., but still indicates a substantial prevalence in this young population.
We used MXA instead of standard spine radiographs for morphometric determination of vertebral deformities. Several studies have documented that MXA is comparable with standard spine radiographs for this approach [34] [35] [36] [37] . MXA, also called as vertebral fracture assessment with DXA, has several advantages over vertebral morphometry on conventional spinal radiographs. The radiation dose is much lower ( < 80 mSv) and assessment of BMD and vertebral deformities can be combined. Although MXA is thus an established technology to detect vertebral fractures and to identify patients likely to benefit from pharmacological therapy who otherwise might not be treated [38] , this technology has some limitations as well. These include limited ability to provide a differential diagnosis for the detected deformities, lower sensitivity for milder fractures, and inability to evaluate the uppermost thoracic levels. Its negative predictive value is, however, high [17] . Other disorders that may cause changes in vertebral shape involve congenital abnormalities and conditions such as severe osteoarthritis [39] and Scheuermann's disease. We have, however, no indications that these relatively rare conditions may have interfered with our observations. In contrast, vertebrae in the midthoracic spine and thoracolumbar junction are slightly more wedged than in other regions of the spine [32, 40] and, as a result, normal variations may be misinterpreted as mild vertebral deformities [41, 42] . This may have contributed to overestimation of vertebral deformities in our series, although, we feel, only to a limited extent.
The occurrence of vertebral deformities in our series was equally distributed among patients with a normal and osteopenic BMD at the hip. Only a few patients had osteoporosis according to the WHO criteria, even when patients on bisphosphonates were included. BMD of patients with vertebral deformities was not different from the other patients studied. These findings are in line with other studies [19] . In one of these studies, bone mass and fracture risk were determined and revealed a reduced BMD of the lumbar spine in patients with vertebral fractures compared with those without vertebral fractures (T-score -2.50 ± 0.88 vs. -2.07 ± 0.66; P < 0.05), but also no relevant differences of BMD at the hip [18] . This is in line with many observations that indicate that low BMD is only one of the components that determines fracture risk and that most fractures [43] , whether clinical or morphometric, occur in patients without osteoporosis in terms of a T-score less than or equal to 2.5 [43] . Therefore, our results support the current trend toward identifying patients at risk for fracture even when BMD is normal [7] , as reflected in the current WHO initiative to develop refined models for fracture prediction in the individual patient [43] . The clinical consequence of our findings is that a more systematic search for vertebral deformities is warranted in CD and UC, as suggested by others [11] .
It is well known that chronic inflammatory diseases affect bone physiology by the production of cytokines [44, 45] such as interleukin-6 and interleukin-17, tumor necrosis factor, the receptor activator of nuclear factor-kB ligand/ osteoprotegerin balance and the Wnt signaling pathway, probably mainly by an influence on bone turnover [46] [47] [48] . We indeed found an increase in bone turnover parameters in both groups of patients, which was more pronounced in CD than in UC. In postmenopausal women, the level of bone turnover has been shown to be as strong a predictor of fractures as the level of BMD, and independent of low BMD [49, 50] . This may be because of an effect of increased bone turnover on bone microarchitecture, in particular a loss of horizontal trabeculae, not reflected in a change of BMD but nevertheless associated with an increased bone fragility and thus fracture risk. This may imply that changes in microarchitecture of bone rather than changes in BMD are involved in the occurrence of vertebral deformities in IBD and that vertebral deformities are therefore a better reflection of bone failure than low BMD. An alternative explanation may be that vertebral deformities in IBD occur during phases of active disease and increased bone turnover and bone loss, with subsequent recovery of bone during improvement of the IBD condition obscuring the relation of BMD with fracture. This is, however, unlikely, as we found no relation between vertebral deformities and current disease activity.
In this study, male sex was a determinant for having a vertebral deformity. In an earlier study, men with CD were at greatest risk for osteoporosis [51] , but no sex difference was shown in studies on fracture risk. Age was the determinant for having more than one vertebral deformity, as it is a determinant in most epidemiological studies on fracture risk in healthy participants [52, 53] . This was also found in a study of 218 patients with CD in which follow-up data at 20 years were compared with those of age-matched and sex-matched controls. An overall risk ratio of 2.2 for a thoraco-lumbar fracture was calculated in this study, with IBD and age as the only determinants and not use of GCs or intestinal resections [54] . In another study, GC use per se appeared also not to be an important risk factor for fractures in IBD, although this study showed an increased fracture risk in CD but not in UC after long-term use of GC [10] . We found that patients with current use of GCs had a higher prevalence of multiple ( > 1) vertebral deformities. This is in line with the view that long-term use of GC is an independent risk factor for fracture [55] .
Limitations of this study are the cross-sectional design and the lack of an age-matched and sex-matched control population. Another limitation is the measurement of BMD in the hip only. This may have been contributed to an underestimation of osteopenia as it cannot be excluded that more influence of BMD on risk of nonclinical vertebral fractures would have been found if DXA of the spine was also performed. As measurement of the hip, however, allows measurement of both trabecular and cortical bone, a recent study shows that for this reason hip measurements may be superior to the spine in overall fracture prediction [56] .
In conclusion, we performed a large cross-sectional outpatient-based study on patients with CD and UC and have demonstrated that in patients with these conditions the prevalence of nonclinical vertebral defor-mities suggestive of vertebral fractures is substantial, even in patients with normal BMD. Disease activity, GC therapy, and known risk factors for fracture seem to be poor predictors for the occurrence of these asymptomatic vertebral deformities, although GC use predicted the presence of multiple deformities. This implies that in addition to screening for osteoporosis by means of a BMD measurement, morphometric assessment of vertebral deformities is warranted in IBD as well. As a vertebral fracture is a strong predictor of a new fracture of the spine or at other sites, one may wonder whether the high prevalence of vertebral deformities in IBD is a reason for preventive treatment as it is recommended for patients with increased fracture risk, such as patients who are treated with supraphysiological doses of GCs. To support this hypothesis, prospective follow-up data on the development of vertebral deformities in patients with IBD are needed.
